Literature DB >> 12144741

Murine models of chronic Pseudomonas aeruginosa lung infection.

Anna M van Heeckeren1, M D Schluchter.   

Abstract

The animal model of chronic bronchopulmonary infection using agarose beads laden with Pseudomonas aeruginosa is frequently utilized in cystic fibrosis research, though it is challenging to perform it in mice. This paper reports the most successful methods for the creation of this model. Transtracheal insertion of a 22 G 1" over-the-needle intravenous catheter to preferentially inoculate the right mainstem bronchus using tribromoethanol anaesthesia administered i.p. was better for a successful surgical outcome compared, respectively, to the use of a 27 G (1/2)" needle, bilateral inoculation or an anaesthetic cocktail of xylazine, acepromazine and ketamine administered i.p. Bilateral infection was associated with higher mortality, greater weight loss and higher levels of bronchoalveolar cytokine concentration, compared to mice infected primarily in the right lung. Mucoid clinical strain PA M57-15 was preferred since mucoid clinical strain PA 2192 led to comparatively more severe lesions and higher mortality. Using the same operator for a given task reduced the variability inherent in this model, illustrated using outcome measures such as gross lung pathology. The response of mice inoculated with P. aeruginosa-laden agarose beads was characterized by bronchopulmonary inflammation, high production of cytokines, and significant weight loss; whereas the response to infection with free-living bacteria was characterized by pneumonia, lower production of cytokines and weight loss. The use of free P. aeruginosa pre-mixed with sterile agarose beads may be considered as an alternative to the use of P. aeruginosa-laden agarose beads, since the histopathological features were similar, though further characterization is needed to evaluate its utility as an adequate model of cystic fibrosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12144741     DOI: 10.1258/002367702320162405

Source DB:  PubMed          Journal:  Lab Anim        ISSN: 0023-6772            Impact factor:   2.471


  59 in total

1.  Long term chronic Pseudomonas aeruginosa airway infection in mice.

Authors:  Marcella Facchini; Ida De Fino; Camilla Riva; Alessandra Bragonzi
Journal:  J Vis Exp       Date:  2014-03-17       Impact factor: 1.355

2.  Interleukin-17 Pathophysiology and Therapeutic Intervention in Cystic Fibrosis Lung Infection and Inflammation.

Authors:  Daniel Hsu; Patricia Taylor; Dave Fletcher; Rolf van Heeckeren; Jean Eastman; Anna van Heeckeren; Pamela Davis; James F Chmiel; Eric Pearlman; Tracey L Bonfield
Journal:  Infect Immun       Date:  2016-08-19       Impact factor: 3.441

3.  IL-23 mediates inflammatory responses to mucoid Pseudomonas aeruginosa lung infection in mice.

Authors:  Patricia J Dubin; Jay K Kolls
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-10-27       Impact factor: 5.464

4.  Influence of high mutation rates on the mechanisms and dynamics of in vitro and in vivo resistance development to single or combined antipseudomonal agents.

Authors:  V Plasencia; N Borrell; M D Maciá; B Moya; J L Pérez; A Oliver
Journal:  Antimicrob Agents Chemother       Date:  2007-04-30       Impact factor: 5.191

5.  Monitoring infection and inflammation in murine models of cystic fibrosis with magnetic resonance imaging.

Authors:  Vipul R Sheth; R Christiaan van Heeckeren; Alma G Wilson; Anna M van Heeckeren; Mark D Pagel
Journal:  J Magn Reson Imaging       Date:  2008-08       Impact factor: 4.813

6.  Hypersusceptibility of cystic fibrosis mice to chronic Pseudomonas aeruginosa oropharyngeal colonization and lung infection.

Authors:  Fadie T Coleman; Simone Mueschenborn; Gloria Meluleni; Christopher Ray; Vincent J Carey; Sara O Vargas; Carolyn L Cannon; Frederick M Ausubel; Gerald B Pier
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-10       Impact factor: 11.205

7.  Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.

Authors:  Theodore J Cory; Susan E Birket; Brian S Murphy; Cynthia Mattingly; Jessica M Breslow-Deckman; David J Feola
Journal:  J Antimicrob Chemother       Date:  2012-12-17       Impact factor: 5.790

Review 8.  Mechanisms of phagocytosis and host clearance of Pseudomonas aeruginosa.

Authors:  Rustin R Lovewell; Yash R Patankar; Brent Berwin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-01-24       Impact factor: 5.464

9.  Nutritional effects on host response to lung infections with mucoid Pseudomonas aeruginosa in mice.

Authors:  Anna M van Heeckeren; Mark Schluchter; Lintong Xue; Juan Alvarez; Steven Freedman; Judith St George; Pamela B Davis
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

10.  HE3286, an oral synthetic steroid, treats lung inflammation in mice without immune suppression.

Authors:  Douglas Conrad; Angela Wang; Raymond Pieters; Ferdinando Nicoletti; Katia Mangano; Anna M van Heeckeren; Steven K White; James M Frincke; Christopher L Reading; Dwight Stickney; Dominick L Auci
Journal:  J Inflamm (Lond)       Date:  2010-10-30       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.